Literature DB >> 24262698

Mastocytosis.

Melody C Carter1, Dean D Metcalfe, Hirsh D Komarow.   

Abstract

Mastocytosis is a disorder of abnormal mast cell proliferation, with clinical features that include flushing, pruritus, abdominal pain, diarrhea, hypotension, syncope, and musculoskeletal pain. These features are the result of mast cell mediator release and infiltration into target organs. Patients of all ages may be affected, although in children, manifestations primarily involve the skin. Most patients with systemic disease have a somatically acquired activating mutation in the KIT oncogene. This article discusses the causes and pathogenesis of mastocytosis, with an overview of the clinical features and the approach to diagnosis, evaluation, and therapy in adults and pediatric patients. Published by Elsevier Inc.

Entities:  

Keywords:  Bone marrow; KIT; Mast cell; Mastocytosis; Skin; Urticaria

Mesh:

Year:  2013        PMID: 24262698      PMCID: PMC3863935          DOI: 10.1016/j.iac.2013.09.001

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  76 in total

1.  Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.

Authors:  Patrizia Bonadonna; Omar Perbellini; Giovanni Passalacqua; Beatrice Caruso; Sabrina Colarossi; Daniela Dal Fior; Luca Castellani; Chiara Bonetto; Francesco Frattini; Annarita Dama; Giovanni Martinelli; Marco Chilosi; Gianenrico Senna; Giovanni Pizzolo; Roberta Zanotti
Journal:  J Allergy Clin Immunol       Date:  2009-01-09       Impact factor: 10.793

Review 2.  Regulatory effects of histamine and histamine receptor expression in human allergic immune responses.

Authors:  C Akdis; M Jutel; M Akdis
Journal:  Chem Immunol Allergy       Date:  2008

Review 3.  Mastocytosis: state of the art.

Authors:  Hans-Peter Horny; Karl Sotlar; Peter Valent
Journal:  Pathobiology       Date:  2007       Impact factor: 4.342

4.  KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities.

Authors:  Irina Maric; Jamie Robyn; Dean D Metcalfe; Michael P Fay; Melody Carter; Todd Wilson; Weiming Fu; Jennifer Stoddard; Linda Scott; Marilyn Hartsell; Arnold Kirshenbaum; Cem Akin; Thomas B Nutman; Pierre Noel; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2007-07-12       Impact factor: 10.793

5.  Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.

Authors:  K Brockow; C Jofer; H Behrendt; J Ring
Journal:  Allergy       Date:  2008-02       Impact factor: 13.146

6.  Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis.

Authors:  K J Aichberger; W R Sperr; K V Gleixner; A Kretschmer; P Valent
Journal:  Eur J Clin Invest       Date:  2008-11       Impact factor: 4.686

7.  Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.

Authors:  Hejin P Hahn; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2007-11       Impact factor: 6.394

8.  Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis.

Authors:  Arturo Vega-Ruiz; Jorge E Cortes; Matjaz Sever; Taghi Manshouri; Alfonso Quintás-Cardama; Raja Luthra; Hagop M Kantarjian; Srdan Verstovsek
Journal:  Leuk Res       Date:  2009-02-03       Impact factor: 3.156

9.  Phenotypic and genotypic characteristics of mastocytosis according to the age of onset.

Authors:  Fanny Lanternier; Annick Cohen-Akenine; Fabienne Palmerini; Frédéric Feger; Ying Yang; Yael Zermati; Stéphane Barète; Beatrix Sans; Cédric Baude; David Ghez; Felipe Suarez; Richard Delarue; Philippe Casassus; Christine Bodemer; Adeline Catteau; Frédérique Soppelsa; Katia Hanssens; Michel Arock; Hagay Sobol; Sylvie Fraitag; Danièle Canioni; Alain Moussy; Jean Marie Launay; Patrice Dubreuil; Olivier Hermine; Olivier Lortholary
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

10.  Case-control cohort study of patients' perceptions of disability in mastocytosis.

Authors:  Olivier Hermine; Olivier Lortholary; Phillip S Leventhal; Adeline Catteau; Frédérique Soppelsa; Cedric Baude; Annick Cohen-Akenine; Fabienne Palmérini; Katia Hanssens; Ying Yang; Hagay Sobol; Sylvie Fraytag; David Ghez; Felipe Suarez; Stéphane Barete; Philippe Casassus; Beatrice Sans; Michel Arock; Jean Pierre Kinet; Patrice Dubreuil; Alain Moussy
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

View more
  25 in total

Review 1.  Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila.

Authors:  Vaibhav Rastogi; Devina Singh; Joseph J Mazza; Dipendra Parajuli; Steven H Yale
Journal:  Clin Med Res       Date:  2018-04-12

2.  Impaired function of bone marrow stromal cells in systemic mastocytosis.

Authors:  Krisztian Nemeth; Todd M Wilson; Jiaqiang J Ren; Marianna Sabatino; David M Stroncek; Miklos Krepuska; Yun Bai; Pamela G Robey; Dean D Metcalfe; Eva Mezey
Journal:  Stem Cell Res       Date:  2015-05-08       Impact factor: 2.020

Review 3.  Immunology of Bee Venom.

Authors:  Daniel Elieh Ali Komi; Farzaneh Shafaghat; Ricardo D Zwiener
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

4.  Fluvastatin Induces Apoptosis in Primary and Transformed Mast Cells.

Authors:  Patrick A Paez; Motunrayo Kolawole; Marcela T Taruselli; Siddarth Ajith; Jordan M Dailey; Sydney A Kee; Tamara T Haque; Brian O Barnstein; Jamie Josephine Avila McLeod; Heather L Caslin; Kasalina N Kiwanuka; Yoshihiro Fukuoka; Quang T Le; Lawrence B Schwartz; David B Straus; David A Gewirtz; Rebecca K Martin; John J Ryan
Journal:  J Pharmacol Exp Ther       Date:  2020-05-20       Impact factor: 4.030

5.  Oxidative Stress in Children with Cutaneous Mastocytosis.

Authors:  Aysegul Ertugrul; Ilknur Bostanci; Ozcan Erel
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-04-28       Impact factor: 0.885

6.  Mastocytosis-derived extracellular vesicles exhibit a mast cell signature, transfer KIT to stellate cells, and promote their activation.

Authors:  Do-Kyun Kim; Young-Eun Cho; Hirsh D Komarow; Geethani Bandara; Byoung-Joon Song; Ana Olivera; Dean D Metcalfe
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-23       Impact factor: 11.205

7.  Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.

Authors:  S Georgin-Lavialle; D S Moura; A Salvador; J-C Chauvet-Gelinier; J-M Launay; G Damaj; F Côté; E Soucié; M-O Chandesris; S Barète; C Grandpeix-Guyodo; C Bachmeyer; M-A Alyanakian; A Aouba; O Lortholary; P Dubreuil; J-R Teyssier; B Trojak; E Haffen; P Vandel; B Bonin; O Hermine; R Gaillard
Journal:  Mol Psychiatry       Date:  2016-01-26       Impact factor: 15.992

8.  [Recurrent skin blisters for more than 7 months in a girl aged 15 months].

Authors:  Ke-Yao Li; Jian-Ping Tang; Xiao-Ting Liang; Zhou-Ying Zhao; Shu-Zhen Yue
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-09

9.  Elevation in histamine and tryptase following exercise in patients with mastocytosis.

Authors:  Joseph M Kulinski; Dean D Metcalfe; Michael L Young; Yun Bai; Yuzhi Yin; Robin Eisch; Linda M Scott; Hirsh D Komarow
Journal:  J Allergy Clin Immunol Pract       Date:  2018-07-23

10.  TET2 regulates immune tolerance in chronically activated mast cells.

Authors:  Riccardo Rigo; Rabie Chelbi; Julie Agopian; Sebastien Letard; Aurélien Griffon; Hussein Ghamlouch; Julien Vernerey; Vasileios Ladopoulos; Edwige Voisset; Paulo De Sepulveda; Geoffrey Guittard; Jacques A Nunès; Ghislain Bidaut; Berthold Göttgens; Michael Weber; Olivier A Bernard; Patrice Dubreuil; Erinn Soucie
Journal:  JCI Insight       Date:  2022-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.